There’s one more number to remember: When Hillenbrand bought Milacron, that also included the Cimcool business, which makes ...
Mitsubishi UFJ Morgan Stanley Securities and BofA Securities are serving as financial advisors, and Morrison Foerster, Mori, Hamada & Matsumoto and Ropes & Gray are serving as legal advisors to Bain ...
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.
Hillenbrand sells majority stake in mechanical engineering company to Bain Capital / Net losses, weak order intake These cookies cannot be deactivated as they are required for basic functions to keep ...
Xiaomi's shares hit a new intraday high in Hong Kong as optimism grew over the earnings outlook for the Chinese consumer-electronics specialist this year. The South Korean internet giant posted ...
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.
Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...
Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results